FMD reduces systemic levels of hydrogen peroxide and leukotrienes as well as the myocardial expression of NLRP-3, leukotrienes and NF-kB in B16-F10 melanoma-bearing mice treated with combinatorial ICIs therapies. This evidence concerns the gene NFKB1 and melanoma.